Back
Salarius Pharmaceuticals, Inc. 10K Form
Sell
14
SLRX
Salarius Pharmaceuticals, Inc.
Last Price:
$0.89
Seasonality Move:
-10.14%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive SLRX News And Ratings
See the #1 stock for the next 7 days that we like better than SLRX
SLRX Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-1.6M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $4.50 |
| Price / Book: | 0.1 |
Profitability
| EPS (TTM): | -24.84590 |
|---|---|
| Net Income (TTM): | $-5M |
| Gross Margin: | $-4.4K |
| Return on Equity: | -316.09% |
| Return on Assets: | -149.74% |
Salarius Pharmaceuticals, Inc. Earnings Forecast
Key Salarius Pharmaceuticals, Inc. Financial Ratios
-
Per Share Earnings over the last 11 years have been positive in 6 years.
Salarius Pharmaceuticals, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | SLRX |
| CUSIP: | 79400X |
| Website: | salariuspharma.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 2.79 |
| Quick Ratio: | 2.6 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
SLRX Technical Analysis vs Fundamental Analysis
Sell
14
Salarius Pharmaceuticals, Inc. (SLRX)
is a Sell
Is Salarius Pharmaceuticals, Inc. a Buy or a Sell?
-
Salarius Pharmaceuticals, Inc. stock is rated a SellThe current Salarius Pharmaceuticals, Inc. [SLRX] share price is $0.87. The Score for SLRX is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.